
Ajay Major/LinkedIn
Dec 9, 2024, 20:03
Ajay Major: CTCL global QOL scores and pruritis improve in both responders and non-responders
Ajay Major, Assistant Professor of Medicine at the University of Colorado School of Medicine, shared a post on X:
“From ASH24 oral:
CTCL global QOL scores and pruritis improve in both responders and non-responders (non-responders just have a delayed improvement).
No patients with Sezary had severe CTCL symptoms by week 81!
PRO benefit in both SS and MF.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 22, 2025, 13:28
Feb 22, 2025, 13:04
Feb 22, 2025, 11:28
Feb 22, 2025, 11:22
Feb 22, 2025, 11:15
Feb 22, 2025, 11:02
Feb 22, 2025, 10:47